Thiazolidinedione use in elderly patients with type 2 diabetes: with and without heart failure

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pharmacoepidemiology and Drug Safety

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pds.2112PMID 21328632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes

  2010cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2008cited by this paper
• Increase in Mortality Rate Following Coprescription of Cisapride and Contraindicated Drugs

  2007cited by this paper
• Triple Therapy in Type 2 Diabetes: Insulin Glargine or Rosiglitazone Added to Combination Therapy of Sulfonylurea Plus Metformin in Insulin-Naïve Patients

  2006cited by this paper
• The incidence of congestive heart failure in type 2 diabetes: an update.

  2004cited by this paper
• Metformin and thiazolidinedione use in Medicare patients with heart failure.

  2003cited by this paper
• Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

  2002cited by this paper
• Nonhypoglycemic Effects of Thiazolidinediones

  2001cited by this paper
• Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

  2001cited by this paper
• Nonhypoglycemic effects of thiazolidinediones.

  2001cited by this paper
• Vital epidemiologic clues in heart failure.

  2000cited by this paper
• Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.

  2000cited by this paper
• The treatment of elderly diabetic patients with acute myocardial infarction: insight from Michigan's Cooperative Cardiovascular Project.

  2000cited by this paper
• Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

  1999cited by this paper
• Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population.

  1999cited by this paper
• CONGESTIVE HEART FAILURE IN OLDER ADULTS * : Epidemiology, Pathophysiology, and Etiology of Congestive Heart Failure in Older Adults

  1997cited by this paper

• Worldwide Availability of Pharmacoepidemiological Databases

  2021cites this paper
• Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors

  2021cites this paper
• Careful use to minimize adverse events of oral antidiabetic medications in the elderly

  2021cites this paper
• Development of algorithms to determine the onset of pregnancy and delivery date using health care administrative data in a university hospital in Japan

  2018cites this paper
• Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study

  2015cites this paper
• Monitoring medicines use to support national medicines policy development and implementation in the Asia Pacific region

  2013cites this paper
• Claims-Based Definition of Death in Japanese Claims Database: Validity and Implications

  2013cites this paper